AbbVie Inc. is 170.8x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($397.44 B vs $2.33 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PBH | ABBV |
|---|---|---|
| Market cap | $2.33 B | $397.44 B |
| US-listed rank | #1987 | #28 |
| Revenue (latest FY) | $1.09B | $61.16B |
| Net income (latest FY) | $190.30M | $4.23B |
| Net margin | 17.5% | 6.9% |
| P/E (trailing FY) | 12.2 | 94.0 |
| SEC filings | 1,235 | 1,008 |
AbbVie Inc. is 170.8x more valuable than Prestige Consumer Healthcare Inc. by market capitalization ($397.44 B vs $2.33 B).
In their latest fiscal years, Prestige Consumer Healthcare Inc. reported $1.09B in revenue while AbbVie Inc. reported $61.16B.
Full pages: Prestige Consumer Healthcare Inc. and AbbVie Inc., or browse the full rankings.